{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:05:59Z","timestamp":1780308359502,"version":"3.54.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,1]],"date-time":"2027-06-01T00:00:00Z","timestamp":1811808000000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.joms.2025.12.019","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:17:14Z","timestamp":1767658634000},"page":"978-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Osteoradionecrosis"],"prefix":"10.1016","volume":"84","author":[{"given":"Yoshiaki","family":"Tadokoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-7084","authenticated-orcid":false,"given":"Takumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5878-8871","authenticated-orcid":false,"given":"Daisuke","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2025.12.019_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.joms.2025.12.019_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2025.12.019_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0278-2391(87)90399-5","article-title":"Osteoradionecrosis: clinical experience and a proposal for classification","volume":"45","author":"Epstein","year":"1987","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0278-2391(83)90294-X","article-title":"Osteoradionecrosis: a new concept of its pathophysiology","volume":"41","author":"Marx","year":"1983","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19116565","article-title":"Factors associated with treatment outcomes and pathological features in patients with osteoradionecrosis: a retrospective study","volume":"19","author":"Tadokoro","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.joms.2025.12.019_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2280002","article-title":"Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors","volume":"55","author":"Cao","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.joms.2025.12.019_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-024-12242-5","article-title":"The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy","volume":"24","author":"Man","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.joms.2025.12.019_bib8","article-title":"Association between systemic inflammatory indicators with the survival of chronic kidney disease: a prospective study based on NHANES","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.joms.2025.12.019_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.joms.2025.12.019_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bjoms.2014.02.017","article-title":"Osteoradionecrosis--A review of current concepts in defining the extent of the disease and a new classification proposal","volume":"52","author":"Lyons","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09553002.2018.1440092","article-title":"Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications","volume":"94","author":"Najafi","year":"2018","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.joms.2025.12.019_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10787-017-0332-5","article-title":"Melatonin as an anti-inflammatory agent in radiotherapy","volume":"25","author":"Najafi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.joms.2025.12.019_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","article-title":"The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway","volume":"73","author":"Delanian","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.joms.2025.12.019_bib14","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.joms.2025.12.019_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities","volume":"6","author":"Nathan","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joms.2025.12.019_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-019-0471-y","article-title":"The regulatory roles of neutrophils in adaptive immunity","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.joms.2025.12.019_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joms.2025.12.019_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12885-020-07063-1","article-title":"Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study","volume":"20","author":"Hasegawa","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.joms.2025.12.019_bib19","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.joms.2025.12.019_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joms.2025.12.019_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","article-title":"Platelet activation in type 2 diabetes mellitus","volume":"2","author":"Ferroni","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.joms.2025.12.019_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/0003319715591751","article-title":"Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction","volume":"67","author":"Ozcan Cetin","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.joms.2025.12.019_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2016.12.006","article-title":"Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study","volume":"150","author":"Ozcan Cetin","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.joms.2025.12.019_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan","year":"2019","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.joms.2025.12.019_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111863","article-title":"Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies","volume":"131","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.joms.2025.12.019_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70108","article-title":"Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"13","author":"Liu","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.joms.2025.12.019_bib27","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1007\/s00405-016-3950-4","article-title":"Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma","volume":"273","author":"Grimm","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.joms.2025.12.019_bib28","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00405-018-4972-x","article-title":"The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis","volume":"275","author":"Tham","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.joms.2025.12.019_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008033","article-title":"Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study","volume":"5","author":"Zhang","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.joms.2025.12.019_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jcms.2017.02.023","article-title":"Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis","volume":"45","author":"Wehrhan","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14219\/jada.archive.1985.0074","article-title":"Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin","volume":"111","author":"Marx","year":"1985","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2025.12.019_bib32","first-page":"585","article-title":"Hyperbaric oxygen as an adjunct in the treatment of osteoradionecrosis of the mandible","volume":"39","author":"Mansfield","year":"1981","journal-title":"J Oral Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.oraloncology.2010.08.007","article-title":"Paradigm shifts in the management of osteoradionecrosis of the mandible","volume":"46","author":"Jacobson","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2025.12.019_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/bjom.1999.0285","article-title":"Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation","volume":"38","author":"Maier","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.12.019_bib35","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1200\/JCO.2004.09.006","article-title":"Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group","volume":"22","author":"Annane","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2025.12.019_bib36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1634\/theoncologist.2016-0298","article-title":"The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber\/Brigham and Women's Cancer Center multidisciplinary guideline","volume":"22","author":"Sultan","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2025.12.019_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2021.11.021","article-title":"Hyperbaric oxygen treatment of mandibular osteoradionecrosis: combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1","volume":"166","author":"Forner","year":"2022","journal-title":"Radiother Oncol"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239125010006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239125010006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:32:25Z","timestamp":1780306345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239125010006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0278239125010006"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2025.12.019","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Osteoradionecrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2025.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}